Biophytis S.A.
Clinical-stage biotech developing therapeutics for age-related degenerative diseases.
ALBPS | PA
Overview
Corporate Details
- ISIN(s):
- FR0012816825 (+4 more)
- LEI:
- 9695008GIE061NBGU106
- Country:
- France
- Address:
- 14 AVENUE DE L'OPERA, 75001 PARIS
- Website:
- https://www.biophytis.com/en/
Description
Biophytis S.A. is a clinical-stage biotechnology company focused on developing therapeutics to slow degenerative processes associated with aging and improve longevity. The company's primary strategy is centered on treating diseases that impair mobility. Its lead drug candidate, BIO101, is being advanced in late-stage clinical development for multiple age-related conditions. A key program is the SARA Phase 3 trial, the first-ever pivotal study for the treatment of sarcopenia (age-related muscle loss). Additionally, BIO101 is being evaluated in the OBA Phase 2 clinical trial for addressing muscle wasting in patients with obesity. The company aims to preserve muscle function and enhance functional outcomes for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-05-22 18:30 |
Biophytis annonce la reprise de la cotation de son titre le 23 mai 2019, à l’ou…
|
French | 194.6 KB | ||
| 2019-05-22 18:30 |
Biophytis announces that trading of the stock will resume on May 23rd, 2019, at…
|
English | 163.8 KB | ||
| 2019-05-22 18:02 |
Biophytis annonce la publication de son Document de référence 2018
|
French | 179.1 KB | ||
| 2019-05-22 18:02 |
Biophytis Announces Publication of its 2018 Annual Report
|
English | 138.9 KB | ||
| 2019-05-22 13:17 |
Biophytis annonce le dépôt d’un document d’enregistrement en vue d’une Introduc…
|
French | 216.0 KB | ||
| 2019-05-22 13:17 |
Biophytis Files Registration Statement for Proposed Initial Public Offering in …
|
English | 184.1 KB | ||
| 2019-05-22 11:52 |
Biophytis annonce la suspension de la cotation de son titre dans l’attente de l…
|
French | 193.7 KB | ||
| 2019-05-22 11:52 |
Biophytis announces suspension of trading until distribution of a press release
|
English | 161.3 KB | ||
| 2019-05-02 18:00 |
Biophytis a présenté un poster au congrès annuel de l’Association for Research …
|
French | 225.4 KB | ||
| 2019-04-16 18:00 |
Biophytis annonce la publication du Rapport Financier 2018 et le départ de Jean…
|
French | 227.5 KB | ||
| 2019-04-16 18:00 |
Biophytis announces the release of the 2018 Annual Financial Report and the dep…
|
English | 251.3 KB | ||
| 2019-04-04 08:00 |
Biophytis participera à plusieurs rencontres investisseurs au cours du mois d’a…
|
French | 226.4 KB | ||
| 2019-04-04 08:00 |
Biophytis to participate in several investors’ events during the month of April
|
English | 177.2 KB | ||
| 2019-03-21 17:00 |
Biophytis annonce la présentation prochaine de posters à des conférences scien…
|
French | 249.9 KB | ||
| 2019-03-21 17:00 |
Biophytis Announces Upcoming Poster Presentations at Scientific Conferences
|
English | 176.9 KB |
Automate Your Workflow. Get a real-time feed of all Biophytis S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Biophytis S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Biophytis S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-11-22 | N/A | Other | Buy | 8,443,190 | 79,365.99 EUR |
| 2020-12-16 | N/A | Other | Sell | 500,000 | 499,000.00 EUR |
| 2020-12-16 | N/A | Other | Other | 313,417 | N/A |
| 2020-04-30 | N/A | Other | Other | 2,955,701 | 177,342.06 EUR |
Peer Companies
